The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida

Infectious Diseases in Obstetrics and Gynecology

Volumn 13, Issue 2, 2005, Pages 69-75

  Strus, Magdalena ^a   Kucharska, Agnieszka ^a   Kukla, Grazyna ^a   Brzychczy Włoch, Monika ^a   Maresz, Katarzyna ^a   Heczko, Piotr B ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antagonistic activities; Candida; Cell surface properties; H2O2; Lactobacillus

Indexed keywords

CATALASE; HYDROGEN PEROXIDE; PROBIOTIC AGENT;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ADHERENCE; CANDIDA ALBICANS; CANDIDA PSEUDOTROPICALIS; CELL CULTURE; CELL SURFACE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LACTOBACILLUS; PREMENOPAUSE; PRIORITY JOURNAL; URINARY TRACT INFECTION; VAGINA CANDIDIASIS; VAGINA EPITHELIUM; VAGINA FLORA;

BACTERIAL ADHESION; CANDIDA; CANDIDIASIS, VULVOVAGINAL; CATALASE; CELL LINE, TUMOR; FEMALE; HUMANS; HYDROGEN PEROXIDE; IMMUNOENZYME TECHNIQUES; LACTOBACILLUS; PROBIOTICS; REAGENT STRIPS; VAGINA;

EID: 22144492235     PISSN: 10647449     EISSN: None     Source Type: Journal    
DOI: 10.1080/10647440400028136     Document Type: Article

References (26)

1. 2-generating lactobacilli. J Infect Dis 1991;164:94-100.
2. Hawes SE, Hillier SL, Benedetti J, et al. Hydrogen peroxide producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996;174:1058-1063.
3. Drutz DJ. Lactobacillus prophylaxis for Candida vaginitis. Ann Intern Med 1992;116:419-420.
4. Strus M, Marewicz E, Kukla G, et al. Surface properties of Lactobacillus strains of human origin. Microb Ecol Health Dis 2001;13:240-245.
5. Pybus V, Onderdonk AB. The effect of pH on growth and succinate production by Prevotella bivia. Microb Ecol Health Dis 1996;9:19-25.
6. McGoarty JA. Probiotic use of lactobacilli in the human female urogenital tract. FEMS Immunol Med Microbiol 1993;6:251-264.
7. Strus M, Malinowska M, Heczko PB. In vitro antagonistic effect of Lactobacillus on organisms associated with bacterial vaginosis. J Reprod Med 2002;47:41-46.
8. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 1991;29:297-301.
9. Walter J, Tannock GW, Tilsala-Timisjarvi A, et al. Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and specific-species PCR primers. Appl Environ Microbiol 2000;1:297-303.
10. Jonsson P, Wadström T. Surface hydrophobicity of Staphylococcus aureus measured by the salt aggregation test (SAT). Curr Microbiol 1984;10:203-210.
11. Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985;22:996-1006.
12. Gaffney RA, Venegas MF, Kanerva C, et al. Effect of vaginal fluid on adherence of type 1 piliated Escherichia coli to epithelial cells. J Infect Dis 1995;172:1528-1535.
13. Fitzsimmons N, Berry DR. Inhibition of Candida albicans by Lactobacillus acidophilus: evidence for the involvement of a peroxidase system. Microbios 1994;80:125-133.
14. Eschenbach DA, Davick PR, Williams BL, et al. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J Clin Microbiol 1989;27:251-256.
15. Fontaine EA, Taylor-Robinson D. Comparison of quantitative and qualitative methods of detecting hydrogen peroxide produced by human vaginal strains of lactobacilli. J Appl Bacteriol 1990;69:326-331.
16. Pick E, Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J Immunol Methods 1981;46:211-226.
17. McGroarty JA, Tomczek L, Pond DG, et al. Hydrogen peroxide production by Lactobacillus species: correlation with susceptibility to the spermicidal compound nonoxynol-9. J Infect Dis 1992;165:1142-1144.
18. Wood ?. Jr, Sweet RL, Katena A, et al. In vitro adherence of Lactobacillus to vaginal epithelial cells. Am J Obstet Gynecol 1985;153:740-743.
19. 2-generating Lactobacillus species for probiotic use. Curr Microbiol 1999;38:279-284.
20. Niku-Paavola ML, Laitila A, Mattila-Sandholm T, Haikara A. New types of antimicrobial compounds produced by Lactobacillus plantarum. J Appl Microbiol 1999;86:29-35.
21. Young G, Resca RG, Sullivan MT. Interactions of oral strains of Candida and Lactobacilli. J Bacteriol 1956;72:525-529.
22. Drutz DJ. Lactobacillus prophylaxis for Candida vaginitis. Ann Intern Med 1992;116:419-420.
23. Klebanoff SJ, Coombs RW. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type I: possible role in heterosexual transmission. J Exp Med 1991;174:289-292.
24. Millar AD, Rampton DS, Blake DR. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis. Aliment Pharmacol Ther 2000;14:1163-1168.
25. Sookkhee S, Chulasiri M, Prachyabrued W. Lactic acid bacteria from healthy oral cavity of Thai volunteers: inhibition of oral pathogens. J Appl Microbiol 2001;90:172-176.
26. Stroem K, Sjoegren J, Broberg A, Schnuerer J. Lactobacillus plantarum MiLAB 393 produces the antifungal cyclic dipeptides cyclo (L-Phe-L-Pro) and cyclo (L-Phe-trans-4-OH-L-Pro) and 3-phenylacetic acid. Appl Environ Microbiol 2002;68:4322-4327.